The dihydropyridine calcium-channel agonist BayK 8644 inhibits the presynaptic effects of R-phenylisopropyl adenosine in the rat hippocampus.
D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / Q000494:pharmacology*; D000241:Adenosine / Q000031:analogs & derivatives*; D000818:Animals; D006624:Hippocampus / Q000187:drug effects*; D008297:Male; D010660:Phenylisopropyladenosine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011983:Receptors, Purinergic / Q000187:drug effects; D013569:Synapses / Q000187:drug effects*
D011983:Receptors, Purinergic; D010660:Phenylisopropyladenosine; D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; D000241:Adenosine